X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    $2 Million Gene Therapy Might Become The Standard In The US

    $2 Million Gene Therapy Might Become The Standard In The US

    Cancer Medicine Prices Jump 53% In Five Years In The U.S

    Food And Drug Administration User Fee Has Been Reauthorized

    Cancer Clinical Trials Get A Brand New Platform In Melbourne

    Report Indicates UK £62bn Behind In Global R&D Investment

    Wall Street Cautiously Optimistic After Gene Therapy Deals

    RoboCap: A Robotic Capsule to Improve Gut Drug Delivery

    Once More, M&As In Biotechechnology Industry Are Thriving

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    $2 Million Gene Therapy Might Become The Standard In The US

    $2 Million Gene Therapy Might Become The Standard In The US

    Cancer Medicine Prices Jump 53% In Five Years In The U.S

    Food And Drug Administration User Fee Has Been Reauthorized

    Cancer Clinical Trials Get A Brand New Platform In Melbourne

    Report Indicates UK £62bn Behind In Global R&D Investment

    Wall Street Cautiously Optimistic After Gene Therapy Deals

    RoboCap: A Robotic Capsule to Improve Gut Drug Delivery

    Once More, M&As In Biotechechnology Industry Are Thriving

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home IPR Data Management

Innovative Analytical Software for Enhanced Data Acquisition and Analysis

Content Team by Content Team
7th June 2021
in IPR Data Management, Press Statements
Thermo Fisher Scientific Launches Modular Closed Cell Processing System for Cell Therapy Manufacturing

Thermo Fisher Scientific (PRNewsfoto/Thermo Fisher Scientific)

Scientists within academia and industries including pharmaceutical, biopharmaceutical and food and beverage analysis, can now benefit from new and improved software capabilities to enhance productivity and usability. The latest software updates enable more strength and flexibility in laboratory workflows in numerous fields, including biotherapeutic characterization, metabolomics and forensic analysis—providing users with intelligent data acquisition and increased confidence in results.

“Researchers and analytical scientists across the life science industry are faced with growing complexity and volume of data, requiring a dependence on software to assist with and automate data acquisition and advance research,” said Mark Sanders, senior director, software platform management, life science mass spectrometry, Thermo Fisher Scientific. “We continually update our suite of software to support the developing needs of our customers, providing laboratories with flexible and user-friendly workflows that enable confidence in their data acquisition.”

Visualizing mass spectral data analysis
The new Thermo Scientific FreeStyle 1.8 SP1 software release provides an advanced data visualization and qualitative analysis software solution for all Thermo Scientific mass spectrometry (MS) instruments. The latest version provides further insight into the data acquisition by reading and displaying extended binary data using the advanced peak determination (APD) algorithm from Thermo Scientific Exploris MS and Thermo Scientific Tribrid MS instruments. New tools for FAIMS method development improve productivity, and an XtractAll feature allows for protein deconvolution of a full chromatogram.

Flexible and complete solution for biotherapeutic analysis
Supporting research scientists in the biopharmaceutical industry and academia laboratories, the newest Thermo Scientific BioPharma Finder 4.1 software brings a complete and flexible solution for the characterization of both protein and oligonucleotide-based biotherapeutics, with new workflows for host cell protein analysis and mRNA mapping for vaccine development. In response to the recent surge in demand for therapeutic oligonucleotide and mRNA workflow solutions, the updated BioPharma Finder software provides one solution for biotherapeutic analysis with enhanced database searching and in silico mRNA digestion tools to support mRNA mapping workflows.

Bringing a collaborative approach to building spectral libraries
The new Thermo Scientific myLibrary Enterprise and myLibrary Pro offer small molecule researchers a unique platform to collaboratively build an online fragmentation spectral library, in research or routine analysis, to share information across an organization. The software utilizes secure cloud-hosting of compound and fragmentation spectral information, while providing researchers with access control through their own Identity Provider.

Improved flexibility for intelligent data acquisition
Researchers in academia, pharmaceutical, and food and beverage industries can now benefit from the Thermo Scientific Xcalibur 4.5 software, providing intelligent data acquisition for small molecule workflows. The latest updates enhance the AcquireX Intelligent Data Acquisition Workflow with more features and flexibility for structural elucidation of metabolites and applications such as metabolomics and lipidomics research, leachable/extractable impurities identification and forensic toxicology. The new Advanced Deep Scan data acquisition workflow allows users to submit several samples in the same experiment and combine inclusion or exclusion lists

Thermo Fisher Scientific will showcase its newest products, software solutions and collaborations in a company-hosted virtual event, “Innovation Summit: Shaping the Future of LC-MS in Life Science Together,” from June 8-10, 2021. Register here to learn more.

About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue exceeding $30 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity in their laboratories, we are here to support them. Our global team of more than 80,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon.

Previous Post

Innovative Mass Spectrometer Designed for Small Molecule Analysis

Next Post

Thermo Fisher Announces Agreement with Advanced Electrophoresis Solutions to Accelerate Therapeutic Development through Cutting-Edge Protein Analysis

Related Posts

IPR Data Management

OPTIMA Has Made AstraZeneca And Mutabor Official Partners

10th October 2022
Press Statements

Final Report ACHEMA 2022

19th September 2022
Empowering the healthcare fraternity through dynamic online courses
Manufacturing

Empowering the healthcare fraternity through dynamic online courses

9th September 2022
Greene Tweed Highlights Materials for Chemical Processing, Life Sciences, and Hydrogen Power Markets at ACHEMA 2022
Manufacturing

Greene Tweed Highlights Materials for Chemical Processing, Life Sciences, and Hydrogen Power Markets at ACHEMA 2022

27th August 2022
AstraZeneca's Enhertu wins keenly-anticipated U.S. breast cancer nod
FDA Approvals

AstraZeneca’s Enhertu wins keenly-anticipated U.S. breast cancer nod

5th August 2022
Big Data Steering Group To Better Data Effectiveness, Search
IPR Data Management

Big Data Steering Group To Better Data Effectiveness, Search

3rd August 2022
Next Post
Thermo Fisher Announces Agreement with Advanced Electrophoresis Solutions to Accelerate Therapeutic Development through Cutting-Edge Protein Analysis

Thermo Fisher Announces Agreement with Advanced Electrophoresis Solutions to Accelerate Therapeutic Development through Cutting-Edge Protein Analysis

Latest News

First Virtual Drug Study Tests 2 Likely Alzheimer Therapies
Clinical Trials

First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

7th November 2022
Facilities & Operation

CPhI Pharma Index Shows Unprecedented Global Pharma Optimism

5th November 2022
$2 Million Gene Therapy Might Become The Standard In The US
Drug Development

$2 Million Gene Therapy Might Become The Standard In The US

5th November 2022
News

Cancer Medicine Prices Jump 53% In Five Years In The U.S

3rd November 2022
FDA Approvals

Food And Drug Administration User Fee Has Been Reauthorized

3rd November 2022
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In